Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles


Balloon Pulmonary Angioplasty: State of the Art

John G Coghlan, Alexander MK Rothman, Stephen P Hoole,


Citation: Interventional Cardiology Review 2021;16:e02.

Interventional Therapies for Resistant Hypertension: A Brief Update

Lisa Brandon, Faisal Sharif,

Citation: Interventional Cardiology Review 2016;11(1):64–9

Vascular Access and Chronic Total Occlusion Angioplasty

David Smith, Ahmed Hailan, Alexander Chase,

Citation: Interventional Cardiology Review 2015;10(2):90–3

Renal Sympathetic Denervation - A Review of Applications in Current…

Vikas Kapil, Ajay K Jain, Melvin D Lobo,

Citation: Interventional Cardiology Review 2014;9(1):54–61